COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

bioRxiv posts many COVID19-related papers. A reminder: they have not been formally peer-reviewed and should not guide health-related behavior or be reported in the press as conclusive.

29,073 Articles (21,549 medRxiv, 7,524 bioRxiv)

Most recent first Previous |  Page 1086: Articles 10851-10860  | Next

Testing Denmark: A Danish nationwide surveillance study of COVID-19
Fogh, K., Strange, J. E., Scharff, B. F., Eriksen, A. R., Hasselbalch, R. B., Bundgaard, H., Nielsen, S. D., Joergensen, C. S., Erikstrup, C., Norsk, J., Nielsen, P. B., Kristensen, J. H., Oestergaard, L., Ellermann-Eriksen, S., Andersen, B., Nielsen, H., Johansen, I. S., Wiese, L., Simonsen, L., Fischer, T. K., Folke, F., Lippert, F., Ostrowski, S. R., Benfield, T., Moelbak, K., Ethelberg, S., Koch, A., Sonksen, U. W., Vangsted, A.-M., Krause, T. G., Formsgaard, A., Ullum, H., Skov, R., Iversen, K.
10.1101/2021.08.10.21261777 — Posted: 2021-08-13
COVID-19 in Connecticut institutions of higher education during the 2020-2021 academic year
Schultes, O., Clarke, V., Paltiel, A. D., Cartter, M., Sosa, L., Crawford, F. W.
10.1101/2021.08.11.21261732 — Posted: 2021-08-13
SARS-CoV-2 variants: levels of neutralisation required for protective immunity
Cromer, D., Steain, M., Reynaldi, A., Schlub, T. E., Wheatley, A. K., Juno, J. A., Kent, S. J., Triccas, J. A., Khoury, D. S., Davenport, M. P.
10.1101/2021.08.11.21261876 — Posted: 2021-08-13
Serological detection of SARS-CoV-2 IgG using a commercially available enzyme immunoassays on dried blood spots collected from patients
Walker, G. J., Davis, R., Naing, Z., McEntee, B., Lu, Y., Denadija, T., Rawlinson, W. D.
10.1101/2021.08.11.21261877 — Posted: 2021-08-13
Molecular and serological investigation of the 2021 COVID-19 case surge in Mongolian vaccinees
Dashdorj, N. J., Dashdorj, N. D., Mishra, M., Danzig, L., Briese, T., Lipkin, W. I., Mishra, N.
10.1101/2021.08.11.21261915 — Posted: 2021-08-13
Clinical course impacts early kinetics and long-term magnitude and amplitude of SARS-CoV-2 neutralizing antibodies beyond one year after infection
Pradenas, E., Trinite, B., Urrea, V., Marfil, S., Tarres-Freixas, F., Ortiz, R., Rovirosa, C., Rodon, J., Vergara-Alert, J., Segales, J., Guallar, V., Valencia, A., Izquierdo-Useros, N., Noguera-Julian, M., Carrillo, J., Paredes, R., Mateu, L., Chamorro, A., Toledo, R., Massanella, M., Clotet, B., Blanco, J.
10.1101/2021.08.12.21261921 — Posted: 2021-08-13
The role of incentives in deciding to receive the available COVID-19 vaccine
Shmueli, L.
10.1101/2021.08.11.21261829 — Posted: 2021-08-13
Infectious SARS-CoV-2 in Exhaled Aerosols and Efficacy of Masks During Early Mild Infection
Adenaiye, O. O., Lai, J., Bueno de Mesquita, P. J., Hong, F. H., Youssefi, S., German, J. R., Tai, S.- H. S., Albert, B. J., Schanz, M., Weston, S., Hang, J., Fung, C. K., Chung, H. K., Coleman, K. K., Sapoval, N., Treangen, T., Maljkovic Berry, I., Mullins, K. E., Frieman, M., Ma, T., Milton, D. K., University of Maryland StopCOVID Research Group
10.1101/2021.08.13.21261989 — Posted: 2021-08-13 Discussion: Onsite
Harmony COVID-19: a ready-to-use kit, low-cost detector, and smartphone app for point-of-care SARS-CoV-2 RNA detection
Panpradist, N., Kline, E., Atkinson, R. G., Roller, M., Wang, Q., Hull, I. T., Kotnik, J. H., Oreskovic, A., Bennett, C., Leon, D., Lyon, V., Gilligan-Steinberg, S., Han, P. D., Drain, P. K., Starita, L. M., Thompson, M. J., Lutz, B. R.
10.1101/2021.08.12.21261875 — Posted: 2021-08-13
Field performance of NowCheck Rapid antigen test for SARS-CoV-2 in Kisumu County, western Kenya
Onsongo, S. N., Otieno, K., van Duijn, S., Barsosio, H., Adams, E. R., Akoth, I., Omollo, C. M., K'Oloo, A., Houben, N., Milimo, E., Aroka, R., Oluoch, F., Odhiambo, A., Kariuki, S., Rinke de Wit, T. F.
10.1101/2021.08.12.21261462 — Posted: 2021-08-13

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).